This text is a result of machine translation.
Biotech Firm ImmuneOnco Submitted Listing Application on the Main Board of HKEX
ImmuneOnco, focusing on developing new-generation tumor immunotherapeutic, will further accelerate the development of other promising drug candidates targeting checkpoints of innate and adaptive immunity.
Yesterday 10:58 PM
NEV Maker Leapmotor Exposed to Rights Protection at Chongqing Auto Show
Leapmotor encountered rights protection at the 2022 Chongqing Auto Show on June 25. It was accused of presenting a black screen on the new car, promising to return the car while regretting the company’s response.
Yesterday 03:41 PM
CLP environmental protection: signed 384 million yuan EPC Contract
A Closer Look at China’s Cloud Service Market, Guessing Who Will Succeed? [1/2]
Jun 27, 2022 05:09 PM
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Jun 27, 2022 12:24 PM